MAPK3 and renal carcinoma: The upregulation of the HIF pathway also leads to activation of tyrosine receptor kinases (RTKs), which initiates the signaling cascade of the Raf/MEK/ERK-1/2 pathway in renal carcinoma cells (Oka et al., 1995).